Semaglutide for Metabolic Dysfunction–Associated Steatohepatitis
Year: 2025
Type: editorial
Source: New England Journal of Medicine
DOI: 10.1056/nejme2504717
Author: Tracey G. Simon
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411015427
